Europe’s medicines watchdog has approved a Covid jab by US-based Novavax, which uses a more conventional technology that the biotech firm hopes will reduce vaccine hesitancy.
In a statement released this Monday, the European Medicines Agency said: “EMA has recommended granting a conditional marketing authorisation for Novavax’s Covid-19 vaccine Nuvaxovid to prevent Covid-19 in people from 18 years of age.”